The Indiana-based drugmaker is slashing the prices of its 2.5 mg single-dose vials to $349 per month and bringing its 5 mg single-dose vials down to $499 per month, it said in a Tuesday press release.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback